Peptide News Digest

#State-Legislation

2 stories

Regulatory · View digest

Utah Asks Diabetes Patients to Share Insulin Costs for Its Lawsuit Against Insulin Makers and PBMs

Utah's Division of Consumer Protection is inviting current and past patients to describe buying and using diabetes medication over the past 10 years, to support the state's November 2023 lawsuit against insulin manufacturers, including Eli Lilly and Novo Nordisk, and pharmacy benefit managers, Utah News Dispatch reported via St. George News. The state says list prices of some insulins rose more than 1,000%. The companies deny the claims, and submissions may be subject to legal discovery.

Regulatory · View digest

NPR: North Dakota Joins 29 States Capping Insulin Costs at $25 a Month After Families Testified in Bismarck

NPR and KFF Health News reported that North Dakota's Republican-majority legislature passed a $25-a-month cap on what patients in state-regulated plans pay for insulin. Insurers and the state chamber of commerce opposed it, warning of higher premiums. Average yearly out-of-pocket insulin costs for privately insured patients fell from $470 in 2018 to $220 in 2025, but state caps do not reach most plans from larger employers, which are typically regulated by the federal government.